Facebook link Linked In link You Tube link

Interventional Immunology

Interventional Immunology

Interventional Immunology 2013

Thursday, June 27, 2013
Boston Seaport Hotel and World Trade Center
1 Seaport Lane 
Boston, Massachusetts, 02210

Course Director

Scott Plevy, MD
Scott Plevy, MD
University of North Carolina
at Chapel Hill
Register Now.  
FOCISed Course Registration Rates
Join FOCIS today! One
Two Course
Three Course
FOCIS Member $150 $250 $350
Non-Member $230 $330 $430
Trainee or Graduate/Medical Student Member $100 $150 $200
Trainee or Graduate/Medical Student Non-Member $130 $180 $230
Industry Member $250 $350 $450
Industry Non-Member $500 $600 $700

Take advantage of reduced package rates by also registering for Basic Immunology in Medicine, Clinical Trials for Immunologic Disease, or both! Join FOCIS today to register at the lowest rates possible.

Target Audience/Purpose

The Interventional Immunology course is intended to familiarize practicing physicians with the scientific basis of novel immune therapies, their clinical applications, and possible side-effects and limitations.

Course Objectives

Upon completion of this activity, the participant should be able to:

  • Identify the scientific basis for choice of immunogically related therapeutic targets in various diseases, including organ specific and systemic autoimmunity, allergy, transplant rejection, cancer, and HIV.
  • Explain the rationale and mechanism underlying the major pharmacologic approaches for interventional immunology in current practice including, anti-cytokine therapy, costimulatory blockade, lymphocyte depletion, adhesion-molecule blockade, and signaling/lymphocyte activation blockade.
  • Evaluate the track record of the different therapeutic approaches in different specialties.
  • Recognize the cross-disciplinary lessons that can be learned from the clinical experience with specific interventions including pharmacological issues, limitations in altering disease progression and complications due to immunosuppression (infections, neoplasias).
  • Analyze how a physician should decide to use and choose therapies.

Preliminary Agenda

8:30 - 9:00 am   Check-in & Continental Breakfast
9:00 - 9:15 am   Welcome and Introductions - Scott Plevy, MD, University of North Carolina at Chapel Hill
9:15 - 10:00 am   B Cell Targeting in Chronic Inflammation: An Update - John Looney, MD, University of Rochester
10:00 - 10:45 am   JAK Inhibitors: Bench to Bedside - John J. O'Shea, MD, National Institutes of Health 
10:45 - 11:00 am   Break 
11:00 am - 11:45 pm   Modulating the Immune System in Type 1 Diabetes - Mark Anderson, MD, PhD, University of California, San Francisco
11:45 - 12:45 pm   Lunch 
12:45 - 1:30 pm   Bringing Biomarkers into Clinical Trials and Clinical Practice - Scott Plevy, MD, University of North Carolina at Chapel Hill
1:30 - 2:15 pm   Immune Intervention in Psoriasis: IL-12, IL-23, IL-17, Or All of the Above? - James Krueger, MD, PhD, Rockefellar University 
2:15 - 3:00 pm   Lymphocyte Depletion in Transplantation: Mechanisms of Tolerance and Clinical Outcomes - Laurence Turka, MD, Massachusetts General Hospital 
3:00 - 3:15 pm   Break 
3:15 - 4:00 pm   Targeting Chemokines in Inflammation and Allergy - Andrew Luster, MD, Massachusetts General Hospital
4:00 - 4:15 pm   Discussion; Adjourn


The Federation of Clinical Immunology Societies is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education credits for physicians.

The Federation of Clinical Immunology Societies designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Course Testimonials

Read what past attendees are saying about the Interventional Immunology course:

  • "Attending this course has definitely sharpened my therapeutic skills as a clinical immunologist."
  • "This was an excellent overview of the basic science underpinning current immunological intervention."

Questions? Please contact This email address is being protected from spambots. You need JavaScript enabled to view it. for more information.